CSF analysis pefiatrics
CSF cerebrospinal fluid analysis pediatrics normal values interpretation
CSF findings meningitis encephalitis children neonates
| Parameter | Neonates (term) | Infants 1–3 mo | Children >3 mo | Adults |
|---|---|---|---|---|
| Opening pressure (cm H₂O) | 2–6 | — | 10–20 | 10–20 |
| Appearance | Clear/xanthochromic | Clear | Clear | Clear |
| WBC (cells/mm³) | ≤16–19 | ≤9–11 | ≤5 | ≤5 |
| Differential | Up to 60% PMNs possible | Mostly lymphocytes | >70% lymphocytes | >70% lymphocytes |
| Protein (mg/dL) | 65–150 (up to 170 preterm) | ≤89–91 | 15–45 | 15–45 |
| Glucose (mg/dL) | 34–119 | 40–80 | 40–80 | 40–80 |
| CSF:serum glucose ratio | ≥0.6 | ≥0.6 | ≥0.6 | ≥0.6 |
Key point: In neonates, up to 19 WBCs/mm³ and protein up to 115–118 mg/dL can be normal. These thresholds drop to 9–11 WBCs/mm³ and ≤89–91 mg/dL by 2 months (per Kestenbaum et al., Pediatrics 2010; Shah et al., J Hosp Med 2011; Thomson et al., Pediatrics 2018 — cited in STI Guidelines, p. 54).
Preterm infants have even higher normal protein levels (up to 170 mg/dL) and higher acceptable WBC counts.
| Feature | Bacterial Meningitis | Viral Meningitis/Encephalitis | TB Meningitis | Fungal Meningitis |
|---|---|---|---|---|
| Appearance | Turbid/cloudy | Clear or slightly turbid | Xanthochromic/turbid | Clear to turbid |
| WBC | 1,000–10,000+ (PMN predominant) | 10–1,000 (lymphocyte predominant) | 100–500 (lymphocyte/monocyte) | 20–500 (lymphocyte) |
| Protein | Markedly elevated (>100 mg/dL) | Normal to mildly elevated | Markedly elevated (>100 mg/dL) | Elevated |
| Glucose | Low (<40 mg/dL or CSF:serum <0.4) | Normal | Very low | Low |
| CSF:serum glucose | <0.4 | ≥0.6 | <0.3 | Low |
| Gram stain | Positive in 60–90% | Negative | Negative (AFB stain rarely+) | Negative (India ink + in Cryptococcus) |
| Cultures | Bacterial culture + | Viral PCR + | Mycobacterial culture (slow) | Fungal culture |
Viral CNS infections show lymphocytic pleocytosis with normal glucose, in contrast to the PMN pleocytosis and hypoglycorrhachia of bacterial meningitis. HSV encephalitis CSF PCR has 96% sensitivity and 99% specificity when checked 72 h after symptom onset (Harrison's, p. 4156).
| Age Group | Common Pathogens |
|---|---|
| 0–28 days | S. agalactiae (GBS), E. coli K1, Listeria monocytogenes, HSV |
| 1–3 months | GBS, E. coli, S. pneumoniae, N. meningitidis |
| 3 months – 5 years | S. pneumoniae, N. meningitidis, H. influenzae (unvaccinated) |
| >5 years | S. pneumoniae, N. meningitidis, Enteroviruses |
| Test | Indication |
|---|---|
| Cell count + differential | Baseline for all LPs |
| Glucose + simultaneous serum glucose | Distinguish bacterial vs. viral |
| Protein | Infection, GBS, demyelination |
| Gram stain + bacterial culture | Suspected bacterial meningitis |
| HSV PCR (types 1 & 2) | Neonates, encephalitis, immunocompromised |
| Enterovirus PCR | Most common viral meningitis in children |
| EBV, CMV, HHV-6 PCR | Encephalitis workup, immunocompromised |
| VDRL | Congenital syphilis (neonates) |
| Cryptococcal antigen | Immunocompromised, TB-endemic regions |
| Oligoclonal bands / IgG index | Suspected MS or demyelinating disease |
| Lactate | Bacterial vs. viral meningitis adjunct |
| Xanthochromia | Subarachnoid hemorrhage |
| Opening pressure | Pseudotumor cerebri, cryptococcal meningitis |
| Condition | Key CSF Findings |
|---|---|
| Guillain-Barré Syndrome | Albuminocytologic dissociation: elevated protein (>45 mg/dL) with normal or near-normal WBC |
| Pseudotumor cerebri | Elevated opening pressure (>25 cm H₂O); otherwise normal |
| Subarachnoid hemorrhage | Bloody in all 3 tubes; xanthochromia develops after 2–4 hours |
| Traumatic tap | Clearing of blood between tubes 1 and 3; no xanthochromia |
| TB meningitis | Fibrin web on standing; very low glucose; high protein |
| Neurosyphilis (congenital) | VDRL positive; pleocytosis; elevated protein |
| Age | Empiric Therapy |
|---|---|
| <1 month | Ampicillin + Cefotaxime (or Gentamicin) ± Acyclovir |
| 1–3 months | Ampicillin + Cefotaxime or Ceftriaxone |
| >3 months | Ceftriaxone + Vancomycin (for resistant pneumococcus) |